{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:09:50Z","timestamp":1789567790874,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.dld.2011.11.010","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T17:16:01Z","timestamp":1324746961000},"page":"334-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"44","author":[{"given":"Federico","family":"Salamone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Galvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Paternostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tibullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Bucchieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mangiameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Parola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Li Volti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2011.11.010_bib0005","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","author":"Musso","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.dld.2011.11.010_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cld.2009.07.008","article-title":"Histopathology of non-alcoholic fatty liver disease","volume":"13","author":"Brunt","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2011.11.010_bib0015","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2011.11.010_bib0020","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.dld.2011.11.010_bib0025","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jhep.2010.06.013","article-title":"Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome","volume":"53","author":"Salamone","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.11.010_bib0030","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.23593","article-title":"Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study","volume":"51","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.11.010_bib0035","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.23741","article-title":"Treating fatty liver for the prevention of cardiovascular diseases","volume":"52","author":"Salamone","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.11.010_bib0040","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","article-title":"Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes","volume":"291","author":"Lautamaki","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dld.2011.11.010_bib0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-144-7-200604040-00011","article-title":"Adiposity of the heart, revisited","volume":"144","author":"McGavock","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2011.11.010_bib0050","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart\u2014an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2011.11.010_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.21983","article-title":"Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver","volume":"47","author":"Perseghin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.11.010_bib0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","article-title":"Fatty liver and lipotoxicity","volume":"1801","author":"Trauner","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.dld.2011.11.010_bib0065","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.freeradbiomed.2007.12.029","article-title":"Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases","volume":"44","author":"Mantena","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.dld.2011.11.010_bib0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/gut.2007.141986","article-title":"Nuclear factor-kappaB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy","volume":"57","author":"Marra","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2011.11.010_bib0075","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/oby.2008.601","article-title":"Liver NF-kappaB and AP-1 DNA binding in obese patients","volume":"17","author":"Videla","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.dld.2011.11.010_bib0080","doi-asserted-by":"crossref","first-page":"E897","DOI":"10.1152\/ajpendo.00509.2009","article-title":"Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization","volume":"298","author":"Brindley","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dld.2011.11.010_bib0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1440-1681.2009.05274.x","article-title":"Reactive oxygen species and insulin-resistant cardiomyopathy","volume":"37","author":"Mellor","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.dld.2011.11.010_bib0090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(94)90053-1","article-title":"Scavenging of reactive oxygen species by silibinin dihemisuccinate","volume":"48","author":"Mira","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dld.2011.11.010_bib0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.510230415","article-title":"Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin","volume":"23","author":"Dehmlow","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.11.010_bib0100","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0016-5085(95)90762-9","article-title":"Antioxidant activity of silybin in vivo during long-term iron overload in rats","volume":"109","author":"Pietrangelo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2011.11.010_bib0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/jhep.2001.26520","article-title":"Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets","volume":"34","author":"Crocenzi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.11.010_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(03)00239-3","article-title":"Silibinin protects mice from T cell-dependent liver injury","volume":"39","author":"Schumann","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.11.010_bib0115","doi-asserted-by":"crossref","first-page":"G1035","DOI":"10.1152\/ajpgi.00199.2004","article-title":"Obese and diabetic db\/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin","volume":"287","author":"Sahai","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2011.11.010_bib0120","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dld.2011.11.010_bib0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/labinvest.2009.112","article-title":"Curcumin limits the fibrogenic evolution of experimental steatohepatitis","volume":"90","author":"Vizzutti","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.dld.2011.11.010_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/CS20030285","article-title":"Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients","volume":"106","author":"Videla","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.dld.2011.11.010_bib0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/gut.2007.147496","article-title":"Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury","volume":"57","author":"Serviddio","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2011.11.010_bib0140","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2011.11.010_bib0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","article-title":"Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?","volume":"142","author":"Halliwell","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dld.2011.11.010_bib0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","article-title":"In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases","volume":"37","author":"Seki","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.11.010_bib0155","first-page":"193","article-title":"A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin\u2013phosphatidylcholine complex (Siliphos)","volume":"10","author":"Kidd","year":"2005","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.dld.2011.11.010_bib0160","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2008.07.072","article-title":"Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon\/ribavirin therapy","volume":"135","author":"Ferenci","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2011.11.010_bib0165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/MCG.0b013e31815cff36","article-title":"Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C","volume":"42","author":"Bares","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2011.11.010_bib0170","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/gut.2006.091967","article-title":"A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations","volume":"55","author":"Federico","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2011.11.010_bib0175","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","article-title":"Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells","volume":"50","author":"Trappoliere","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.11.010_bib0180","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-l-methionine and glutathione","volume":"285","author":"Caballero","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2011.11.010_bib0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.14.193","article-title":"Nonalcoholic fatty liver disease and mitochondrial dysfunction","volume":"14","author":"Wei","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2011.11.010_bib0190","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2011.11.010_bib0195","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1124\/jpet.109.161612","article-title":"A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis","volume":"332","author":"Serviddio","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dld.2011.11.010_bib0200","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1089\/ars.2009.2611","article-title":"Redox regulation of tumor necrosis factor signaling","volume":"11","author":"Han","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.dld.2011.11.010_bib0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1089\/ars.2009.2930","article-title":"Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure","volume":"13","author":"Khaper","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.dld.2011.11.010_bib0210","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.21313","article-title":"Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob\/ob mice","volume":"44","author":"Garcia-Ruiz","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl. 10","key":"10.1016\/j.dld.2011.11.010_bib0215","first-page":"43","article-title":"The role of IL-6 in mediating the anti-inflammatory effects of exercise","volume":"57","author":"Petersen","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.dld.2011.11.010_bib0220","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hep.20400","article-title":"Interleukin 6 alleviates hepatic steatosis and ischemia\/reperfusion injury in mice with fatty liver disease","volume":"40","author":"Hong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2011.11.010_bib0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1753425909104900","article-title":"Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis","volume":"15","author":"S\u00e1nchez-Garrido","year":"2009","journal-title":"Innate Immun"},{"key":"10.1016\/j.dld.2011.11.010_bib0230","first-page":"73","article-title":"Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits","volume":"58","author":"Chabowski","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.dld.2011.11.010_bib0235","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/labinvest.2010.143","article-title":"Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine\u2013choline-deficient diet","volume":"90","author":"Kassel","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.dld.2011.11.010_bib0240","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2353\/ajpath.2006.050953","article-title":"A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury","volume":"169","author":"Svegliati-Baroni","year":"2006","journal-title":"Am J Pathol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811004373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865811004373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:48:37Z","timestamp":1716832117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865811004373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1590865811004373"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2011.11.010","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2011.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}